| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 01/02/2004 | EP1373516A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins and uses thereof |
| 01/02/2004 | EP1373514A2 Phosphorylation modifications of apoptin |
| 01/02/2004 | EP1373513A2 Streptococcus pneumoniae proteins and nucleic acids |
| 01/02/2004 | EP1373511A2 Genes and proteins, and their uses |
| 01/02/2004 | EP1373510A2 Mutant allergens |
| 01/02/2004 | EP1373509A2 Desoxyribonucleic acids coding for the equine ige-allotype heavy chain constant region, the recombinant immunoglobulin obtained therewith and corresponding isotype-specific monoclonal antibodies and the utilization thereof |
| 01/02/2004 | EP1373508A2 Human cytokine receptor |
| 01/02/2004 | EP1373485A2 Ikk2 variant, dino gene, lectin-like receptor gene, and proteins encoded thereby |
| 01/02/2004 | EP1373477A2 A novel virus (cryptovirus) within the rubulavirus genus and uses therefor |
| 01/02/2004 | EP1373322A1 Novel compound for treatment of allergy and asthma |
| 01/02/2004 | EP1373321A2 Modified antibodies and methods of use |
| 01/02/2004 | EP1373320A2 Method for preparing and selecting antibodies |
| 01/02/2004 | EP1373319A2 Composition comprising il-22 inhibitors and use thereof for treating inflammatory disorders |
| 01/02/2004 | EP1373318A2 Neutralizing human monoclonal antibodies against hiv-1, their production and uses |
| 01/02/2004 | EP1373317A2 Nuclear hormone receptor ligand binding domains |
| 01/02/2004 | EP1373316A2 Nuclear hormone receptor ligand binding domain |
| 01/02/2004 | EP1373315A2 Nuclear hormone receptor ligand binding domain |
| 01/02/2004 | EP1373313A2 Proteins and nucleic acids encoding same |
| 01/02/2004 | EP1373310A2 Staphylococcus aureus proteins and nucleic acids |
| 01/02/2004 | EP1373308A2 Multimerization of hiv-1 vif protein as a therapeutic target |
| 01/02/2004 | EP1373306A2 Cytoskeletion-associated proteins |
| 01/02/2004 | EP1373301A2 Reducing the immunogenicity of fusion proteins |
| 01/02/2004 | EP1373293A1 Steap-related protein |
| 01/02/2004 | EP1372741A2 Morpholino imaging and therapy |
| 01/02/2004 | EP1372724A2 Use of immunoregulatory antibodies in the treatment of neoplastic disorders |
| 01/02/2004 | EP1372722A1 Method for prophylaxis and treatment of porcine reproductive and respiratory syndrome |
| 01/02/2004 | EP1372720A1 Methods of preventing or treating inflammatory or autoimmune disorders by administering integrin alphav beta3 antagonists |
| 01/02/2004 | EP1372719A2 Nucleic acid and corresponding protein entitled 125p5c8 useful in treatment and detection of cancer |
| 01/02/2004 | EP1372718A2 Production and use of novel peptide-based agents for use with bi-specific antibodies |
| 01/02/2004 | EP1372717A2 Combination treatment of pancreatic cancer |
| 01/02/2004 | EP1372716A2 Blood cell production via activation of the hemoglobin scavenger receptor (cd163) |
| 01/02/2004 | EP1372715A2 Method for treating cancer using a33 specific antibodies and chemotherapeutic agents |
| 01/02/2004 | EP1372712A2 Equine herpesvirus vaccine |
| 01/02/2004 | EP1372698A2 Use of cytokines of the tgf-beta superfamily for the treatment and diagnosis of skin related disorders |
| 01/02/2004 | EP1372690A2 93870, a human g-protein coupled receptor and uses therefor |
| 01/02/2004 | EP1015495B1 Peptide sequences as hinge regions in proteins like immunoglobulin fragments and their use in medicine |
| 01/02/2004 | EP0871484B9 Prophylactic immune milk preparation against otitis |
| 01/02/2004 | EP0663008B1 Improvements in or relating to immune response modification |
| 01/01/2004 | US20040003427 Novel basal endosperm transfer cell layer (BELT) specific genes |
| 01/01/2004 | US20040003425 Nav2 channel gene-deficient non-human animals |
| 01/01/2004 | US20040003419 Novel taste receptors in Drosophila |
| 01/01/2004 | US20040003418 Nucleic acid and corresponding protein entitled 158P3D2 useful in treatment and detection of cancer |
| 01/01/2004 | US20040002590 Tumour necrosis factor peptide binding antibodies |
| 01/01/2004 | US20040002589 Tumour necrosis factor peptide binding antibodies |
| 01/01/2004 | US20040002588 Ligands which bind to human tumour necrosis factor alpha (TNF) in a manner that modifies the TNF |
| 01/01/2004 | US20040002587 Fc region variants |
| 01/01/2004 | US20040002585 Mucin fusion polypeptide vaccines, compositions and methods of use thereof |
| 01/01/2004 | US20040002583 An antibody or fragment thereof binding specifically to human dietary enzymes such as human lipases; comprising a heavy chain variable domain derived from an immunoglobulin naturally devoid of light chains |
| 01/01/2004 | US20040002460 Spheron components useful in determining compounds capable of treating symptoms of Alzheimer's disease, and treatments and animal models produced therefrom |
| 01/01/2004 | US20040002450 Y17 - isolated molecules comprising epitopes containing sulfated moieties, antibodies to such epitopes, and uses thereof |
| 01/01/2004 | US20040002439 Human voltage gated sodium channel beta1A subunit and methods of use |
| 01/01/2004 | US20040002168 Apparatus and methods for detecting cerebrospinal fluid |
| 01/01/2004 | US20040002146 Enzyme-protein complex |
| 01/01/2004 | US20040002135 Adapted NS0 cell lines with the ability to grow under glutamine-free conditions |
| 01/01/2004 | US20040002134 Novel nucleic acid sequences encoding human KIAA0768 protein-like and human protein PRO228-like polypeptides |
| 01/01/2004 | US20040002127 Expression vector containing the polynucleotide; cell transformation; use in diganostics and as substrate for luminescent reactions; coelenterazine |
| 01/01/2004 | US20040002114 Nucleic acids encoding a G-protein coupled receptor involved in islet cell signaling |
| 01/01/2004 | US20040002088 Identification and isolation of novel DNA and to the recombinant production of polypeptides having sequence similarity to Glial Cell line-derived Neurotrophic Factor Receptor (GDNFR) |
| 01/01/2004 | US20040002087 Nucleic acid for detecting endocrine disrupting property of chemical substance, nucleic acid detecting probe and nucleic acid detecting primer containing the nucleic acid, probe-immobilized chip comprising the nucleic acid detecting probe, peptide derived from the nucleic acid and antibody recognizing the peptide, probe-immobilized chip comprising the antibody, and method of detecting endocrine disrupting property of chemical substance using them |
| 01/01/2004 | US20040002086 Monoclonal antibody for Nkx3.1 and method for detecting the same |
| 01/01/2004 | US20040002066 36 human secreted proteins |
| 01/01/2004 | US20040002057 Cloning vectors and methods for producing a library of DNA molecules capable of expressing a fusion polypeptide on the surface of a filamentous phage particle |
| 01/01/2004 | US20040001863 Immortal cell line derived from grouper Epinephelus coioides and its applications therein |
| 01/01/2004 | US20040001852 Deactivation antigen protein; anticancer agents; Aids therapy |
| 01/01/2004 | US20040001842 Inducing antibodies in situ; binding; antitumor agents, anticancer agents |
| 01/01/2004 | US20040001840 Cancer-linked gene as target for chemotherapy |
| 01/01/2004 | US20040001839 Anticancer agents; antiinflammatory agents; autoimmune diseases |
| 01/01/2004 | US20040001836 Mixture of polypeptide with carrier |
| 01/01/2004 | US20040001835 Prevention or treatment of cancer using integrin alphavbeta3 antagonists in combination with other agents |
| 01/01/2004 | US20040001834 From cytosol; separation by chromatography; using antibody; forming arachidonic acid |
| 01/01/2004 | US20040001832 Childhood obesity; antidiabetic agents; culture product; hybrid nucleic acid |
| 01/01/2004 | US20040001831 Methods and compositions for the diagnosis and treatment of demyelinating inflammatory disorders |
| 01/01/2004 | US20040001830 Prevention binding, coagulation; cardiovascular disorders, sepsis, antiinflammatory agents; using monoclonal antibodies |
| 01/01/2004 | US20040001829 Methods for selectively stimulating proliferation of T cells |
| 01/01/2004 | US20040001828 Treatment methods using anti-CD22 antibodies |
| 01/01/2004 | US20040001827 Modulate tissue distribution |
| 01/01/2004 | US20040001826 Genetic engineering; binding collagen to glycoprotein; hemostatic response to injury |
| 01/01/2004 | US20040001825 Antibody binding to glycoprotein; therapy, diagnosis of cancer |
| 01/01/2004 | US20040001824 Cell proliferation inhibitors |
| 01/01/2004 | US20040001822 Y1-isolated molecules comprising epitopes containing sulfated moieties, antibodies to such epitopes, and uses thereof |
| 01/01/2004 | US20040001804 LLT uses thereof in immune system modulation |
| 01/01/2004 | US20040001790 Methods for diagnosis and treatment of tumours |
| 01/01/2004 | US20040001789 Diagnosis, cancer therapy; using monoclonal antibodies |
| 12/31/2003 | WO2004001655A1 Methods of treating and preventing colitis involving il-13 and nk-t cells |
| 12/31/2003 | WO2004001381A2 Novel raag10 cell surface target and a family of antibodies recognizing that target |
| 12/31/2003 | WO2004001069A2 Compositions and methods for detecting pathologies affecting neuromuscular transmission |
| 12/31/2003 | WO2004001064A2 Serum protein-associated target-specific ligands and identification method therefor |
| 12/31/2003 | WO2004001035A1 Method for generating monoclonal antibodies |
| 12/31/2003 | WO2004001007A2 Buffered formulations for concentrating antibodies and methods of use thereof |
| 12/31/2003 | WO2004001004A2 Membrane associated tumor endothelium markers |
| 12/31/2003 | WO2004000997A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 12/31/2003 | WO2004000996A2 Nucleotide sequences that code for torsin genes, torsin proteins, and methods of using the same to treat protein-aggregation |
| 12/31/2003 | WO2004000884A2 Compositions and methods for apo-b48 and apo-b100 assay |
| 12/31/2003 | WO2004000352A1 Therapeutic compound against leishmania infection and use thereof |
| 12/31/2003 | WO2004000238A2 Utilization of mhc class ii binding motifs in immunization to produce immune serum, monoclonal antibodies and vaccines |
| 12/31/2003 | WO2004000217A2 Vaccines for suppressing ige-mediated allergic disease and methods for using the same |
| 12/31/2003 | WO2004000216A2 Anti-tenascin antibody fragments and minibodies for treatment of lymphoma |
| 12/31/2003 | WO2004000102A2 Method for predicting response to epidermal growth factor receptor-directed therapy |
| 12/31/2003 | WO2003089451A3 Antibodies specific for mucin polypeptide |
| 12/31/2003 | WO2003074567A3 Internalizing anti-cd74 antibodies and methods of use |